<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Akili-Interactive on Bioecon</title><link>https://en.bioecon.ru/companies/akili-interactive/</link><description>Recent content in Akili-Interactive on Bioecon</description><generator>Hugo</generator><language>en-US</language><lastBuildDate>Mon, 20 Jul 2026 22:09:50 +0700</lastBuildDate><atom:link href="https://en.bioecon.ru/companies/akili-interactive/index.xml" rel="self" type="application/rss+xml"/><item><title>Digital therapeutics</title><link>https://en.bioecon.ru/technology/digital-therapeutics/</link><pubDate>Mon, 20 Jul 2026 00:00:00 +0000</pubDate><guid>https://en.bioecon.ru/technology/digital-therapeutics/</guid><description>Software-as-medical-device treatments that deliver a regulator-cleared clinical intervention rather than general wellness support — prescription digital therapeutics for ADHD, insomnia, anxiety and depression, musculoskeletal digital rehabilitation and pediatric autism intervention: Akili Interactive, Big Health and Click Therapeutics in the US, Kaia Health in Germany, and ALSOLIFE in China.</description></item></channel></rss>